PLAT |
PLAT: Tissue-type plasminogen activator precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
1.012 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.012 |
Evidence |
|
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.012 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.012 |
Evidence |
|
F7 |
F7: Coagulation factor VII precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
1.012 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.012 |
Evidence |
|
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.012 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.012 |
Evidence |
|
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
1.012 |
Evidence |
|
TFAP4 |
TFAP4: Transcription factor AP-4 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
NOTCH3 |
NOTCH3: Neurogenic locus notch homolog protein 3 precursor |
JAG2 |
JAG2: Jagged-2 precursor |
1.012 |
Evidence |
|
MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
MAX |
MAX: Protein max |
1.012 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
MAX |
MAX: Protein max |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.012 |
Evidence |
|
HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
MAX |
MAX: Protein max |
1.012 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
1.012 |
Evidence |
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.012 |
Evidence |
|
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
1.012 |
Evidence |
|
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
1.012 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.012 |
Evidence |
|
KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
1.012 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
1.012 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
MAX |
MAX: Protein max |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
1.012 |
Evidence |
|